KRT18 and COVID-19: Since the brain manifestation is a non-COVID-19-disease-specific outcome of the K18-hACE2 mouse model and associated to the artificial expression of the human ACE2 receptor molecule in the brain [78], it might be interesting to test the emergency vaccination regimen in another animal model without the dominant brain manifestation and neurological outcome.